New device aims to curb dangerous bleeding in heart surgery patients on blood thinners
NCT ID NCT07284199
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a device called CA330 that filters blood during heart surgery to reduce severe bleeding. It includes 120 adults on blood thinners who need non-elective heart surgery. Participants are randomly assigned to receive either the filter plus standard care or standard care alone, and researchers track bleeding, transfusions, and recovery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC DISSECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Center for Cardiac Intensive Care, Beijing Anzhen Hospital, Capital Medical University
Beijing, Beijing Municipality, 100029, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can big data unlock the secrets of a deadly aortic emergency?
- Could skipping the breathing tube speed heart surgery recovery?
- Timing is everything: could physiotherapy minutes after extubation prevent lung complications?
- Pre-surgery exercise program may help high-risk heart patients leave the hospital sooner
- Massive chest pain registry reveals gaps between guidelines and real-world care in china
- New registry aims to unlock mysteries of Pregnancy-Related aortic tears